Ella Mendelson Selected Research

Antibodies

1/2023	Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel (ICoFS): a prospective cohort study.
11/2022	Omicron BA.2.75 variant is efficiently neutralised following BA.1 and BA.5 breakthrough infection in vaccinated individuals, Israel, June to September 2022.
6/2022	The Concordance between Mumps and Rubella Sero-Positivity among the Israeli Population in 2015.
3/2022	Existence of immunological memory response in true sero-negative individuals post COVID-19 molecular diagnosis.
2/2022	Rapid Decline of Zika Virus IgM Antibodies against the NS1 Protein in Imported Israeli Cases.
1/2022	COVID-19 vaccination and BA.1 breakthrough infection induce neutralising antibodies which are less efficient against BA.4 and BA.5 Omicron variants, Israel, March to June 2022.
1/2022	Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose.
12/2021	Immunoglobulin (Ig)A seropositivity against SARS-CoV-2 in healthcare workers in Israel, 4 April to 13 July 2020: an observational study.
1/2021	Seropositivity of measles antibodies in the Israeli population prior to the nationwide 2018 - 2019 outbreak.
1/2020	Comprehensive Analyses of SARS-CoV-2 Transmission in a Public Health Virology Laboratory.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ella Mendelson Research Topics

Disease

43	Infections 12/2023 - 04/2004
17	Human Influenza (Influenza) 01/2022 - 02/2005
15	COVID-19 07/2023 - 01/2020
13	Poliomyelitis (Polio) 05/2023 - 05/2006
5	West Nile Fever 01/2018 - 06/2004
4	Mumps 06/2022 - 03/2009
4	Rubella (German Measles) 06/2022 - 03/2009
4	Measles 06/2022 - 03/2009
4	Vaccinia 04/2011 - 12/2004
3	Breakthrough Infections 01/2023 - 01/2022
2	Virus Diseases (Viral Diseases) 06/2022 - 01/2021
2	Chickenpox 06/2022 - 01/2007
2	Zika Virus Infection 02/2022 - 06/2016
2	Viremia 01/2018 - 01/2016
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2011 - 12/2002
2	Ankylosing Spondylitis 07/2011 - 06/2010
2	Rheumatoid Arthritis 06/2010 - 01/2010
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2023
1	Chronic Hepatitis B 11/2022
1	Severe Acute Respiratory Syndrome 02/2021
1	Respiratory Syncytial Virus Infections 10/2020
1	Asymptomatic Infections 01/2020
1	Hepatitis A (Hepatitis, Infectious) 10/2017
1	Bites and Stings (Sting) 01/2017
1	Paralysis (Palsy) 01/2017
1	Persistent Infection 01/2016
1	Liver Diseases (Liver Disease) 11/2015
1	Necrosis 03/2015
1	Sepsis (Septicemia) 01/2015
1	HIV Infections (HIV Infection) 07/2014
1	Vitelliform Macular Dystrophy 02/2014
1	Hearing Loss (Hearing Impairment) 06/2013
1	Ulcer 03/2012
1	Dyspnea (Shortness of Breath) 03/2012
1	Dyspepsia (Indigestion) 03/2012
1	Cough 03/2012
1	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2012
1	Deglutition Disorders (Dysphagia) 03/2012
1	Systemic Scleroderma (Systemic Sclerosis) 03/2012
1	Communicable Diseases (Infectious Diseases) 01/2012
1	Parotitis (Parotiditis) 05/2011
1	Joint Diseases (Joint Disease) 06/2010
1	Neoplasms (Cancer) 05/2010
1	Smallpox (Variola) 05/2010

Drug/Important Bio-Agent (IBA)

35	VaccinesIBA 12/2023 - 05/2006
18	AntibodiesIBA 01/2023 - 06/2004
17	Immunoglobulin G (IgG)IBA 01/2023 - 01/2007
12	BNT162 VaccineIBA 12/2023 - 01/2021
10	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022 - 12/2002
8	RNA (Ribonucleic Acid)IBA 11/2022 - 04/2006
6	Neutralizing AntibodiesIBA 01/2023 - 05/2010
6	EnzymesIBA 08/2022 - 06/2004
5	Immunoglobulin M (IgM)IBA 02/2022 - 03/2009
4	Immunoglobulin A (IgA)IBA 12/2022 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2015
3	N-(2-cyanoethylene)urea (BA 1)IBA 07/2023 - 01/2022
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022 - 02/2005
3	WastewaterIBA 11/2021 - 01/2017
3	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2010
3	Oseltamivir (Tamiflu)FDA Link 05/2010 - 03/2009
2	mRNA VaccinesIBA 01/2023 - 01/2022
2	N-methyl-valyl-amiclenomycin (BA 2)IBA 11/2022 - 01/2022
2	ImmunosorbentsIBA 06/2022 - 05/2010
2	InterferonsIBA 01/2021 - 10/2020
2	AntigensIBA 01/2021 - 03/2012
2	C-Reactive ProteinIBA 03/2012 - 06/2010
2	Infliximab (Remicade)FDA Link 06/2010 - 01/2010
2	Immunoglobulins (Immunoglobulin)IBA 05/2010 - 05/2009
1	IntegrasesIBA 12/2023
1	A-factor (Streptomyces)IBA 01/2023
1	insulin receptor-related receptor (IRR)IBA 12/2022
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2022
1	varicella vaccine rubella mumps measlesIBA 06/2022
1	Messenger RNA (mRNA)IBA 11/2021
1	Angiotensin-Converting Enzyme 2IBA 01/2021
1	CyclinsIBA 01/2021
1	BuffersIBA 01/2021
1	SolutionsIBA 01/2021
1	Hemagglutinins (Hemagglutinin)IBA 02/2020
1	Combined VaccinesIBA 01/2018
1	Leflunomide (Arava)FDA LinkGeneric 11/2017
1	Hepatitis A AntibodiesIBA 10/2017
1	Insect RepellentsIBA 01/2017
1	Amino Acids FDA Link 01/2016
1	SimeprevirIBA 11/2015
1	daclatasvirIBA 11/2015
1	Antirheumatic Agents (DMARD)IBA 03/2015
1	Tumor Necrosis Factor InhibitorsIBA 03/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2015
1	Ganciclovir (Cytovene)FDA LinkGeneric 06/2013
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 03/2012
1	Iloprost (Ventavis)FDA Link 03/2012
1	Subunit VaccinesIBA 03/2012
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2012
1	rubella antibodiesIBA 08/2011
1	Biomarkers (Surrogate Marker)IBA 04/2011

Therapy/Procedure

3	Therapeutics 11/2015 - 04/2010
1	Organ Transplantation 10/2018
1	Protective Clothing 01/2017
1	Radiotherapy 05/2010